Tom Ksiazek & Moderna

Tom Ksiazek: Tom Ksiazek, a virologist and veterinarian, provides historical context on the Bundibugyo virus, having directed the United States — Centers for Disease Control and Prevention's Special Pathogens Branch when the virus was first identified in 2007.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Tom Ksiazek: Tom Ksiazek>>>, a virologist, directed the group that first identified the Bundibugyo virus during the 2007 outbreak in Uganda — Bundibugyo District>>>.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

Tom Ksiazek: Tom Ksiazek>>>, a virologist, directed the group that first identified the Bundibugyo virus during the 2007 outbreak in Uganda — Bundibugyo District>>>.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.